Raphael M, Debré P, Guigui B, Binet J L
Département d'Hématologie, CHU Pitié-Salpêtrière, Paris, France.
Nouv Rev Fr Hematol (1978). 1988;30(5-6):379-83.
The morphological patterns of 20 lymph node biopsies from well differentiated lymphocytic proliferation (CLL and DWDL) were studied using conventional morphology and morphometric technics; immunohistochemistry analysis were performed in 12 cases. Four subtypes of histological patterns were described according to the number and the distribution of large lymphoïd cells. These aspects were compared to the nuclear area distribution curve and clinical staging. Patients with numerous large lymphoïd cells had a right deviation of the curve and were clinically stage C. In stage B patients, the analysis of nuclear area distribution curve individualized patients with a worse prognosis. In 12 cases immunohistochemical technics were applied to determine SmIg, B cell differentiation antigens (CD19, CD20, CD21, BL14, FmC7) and T cells subsets (CD2, CD3, CD4, CD8) the quantification of the various T cell subsets showed that CD3, CD4, positive T cell were lower in advanced stages of CLL.
采用传统形态学和形态计量学技术研究了20例高分化淋巴细胞增殖(慢性淋巴细胞白血病和弥漫性小淋巴细胞淋巴瘤)淋巴结活检的形态学模式;对12例进行了免疫组织化学分析。根据大淋巴细胞的数量和分布描述了四种组织学模式亚型。将这些方面与核面积分布曲线和临床分期进行了比较。大淋巴细胞数量较多的患者曲线右移,临床分期为C期。在B期患者中,核面积分布曲线分析可区分出预后较差的患者。在12例中应用免疫组织化学技术测定表面膜免疫球蛋白、B细胞分化抗原(CD19、CD20、CD21、BL14、FmC7)和T细胞亚群(CD2、CD3、CD4、CD8),各种T细胞亚群的定量分析显示,慢性淋巴细胞白血病晚期CD3、CD4阳性T细胞较低。